BDKRB1 and central nervous system cancer: Bradykinin stimulates the migration of glioma cells by upregulating the expression of cyclo-oxygenase 2 and activating the bradykinin 1 receptor and the PI3K/Akt, AP1, and c-Jun signaling pathways [41].